V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330008247 | 330005035 | 1.47 | 91.3 | Disease modification (D) | 2017-07-01 | 2017-07-01 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330016135 | LIPOSOMAL DOXORUBICIN |
| 330008248 | 330005036 | 1.78 | 73 | Curative (C) | 2017-09-08 | 2017-09-14 | Azacitidine | N | N | 330016165 | TEMOZOLOMIDE |
| 330008249 | 330005037 | null | 13.4 | Adjuvant (A) | 2018-04-10 | 2018-04-10 | Irinotecan + Temozolomide | N | N | 330016168 | IRINOTECAN + TEMOZOLOMIDE |
| 330008250 | 330008756 | null | 84.7 | Curative (C) | 2015-09-11 | 2015-10-02 | Liposomal Doxorubicin (Caelyx) | N | N | 330016173 | LIPOSOMAL DOXORUBICIN |
| 330008251 | 330005040 | null | 55.8 | null | 2015-09-02 | 2015-12-16 | DA 3+8 | N | N | 330016202 | DA |
| 330008252 | 330005041 | 1.64 | 86.6 | Palliative (P) | 2016-08-16 | 2016-08-16 | Docetaxel 75mg/m2 (21 day) | N | N | 330016204 | DOCETAXEL |
| 330008253 | 330005045 | 1.86 | 64 | Curative (C) | 2016-08-14 | 2016-08-15 | CISPLATIN + ETOPOSIDE | null | N | 330016208 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008254 | 330005046 | null | 49.9 | Palliative (P) | 2014-09-18 | 2014-10-03 | Trabectedin | N | N | 330016224 | TRABECTEDIN |
| 330008255 | 330005047 | null | 27.5 | Curative (C) | 2015-12-22 | 2016-01-13 | GemCarbo Days 1+8 | N | N | 330016224 | GEMCARBO |
| 330008256 | 330012485 | 1.8 | 79.8 | Curative (C) | 2016-07-30 | 2016-08-11 | DA 3+8 | N | N | 330016234 | CISPLATIN + DOXORUBICIN |
| 330008257 | 330005049 | null | 65.8 | null | 2016-11-28 | 2016-12-07 | Etoposide oral | N | N | 330016238 | ETOPOSIDE |
| 330008258 | 330005051 | 0 | 11.8 | Curative (C) | 2015-08-19 | 2015-08-19 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330016238 | LIPOSOMAL DOXORUBICIN |
| 330008259 | 330005053 | 1.69 | 50.8 | Curative (C) | 2014-09-18 | 2014-10-23 | Cyclophosphamide + Topotecan | N | null | 330016249 | VINBLASTINE |
| 330008260 | 330005053 | null | 61.8 | Palliative (P) | 2014-07-17 | 2014-07-18 | GemCarbo Days 1+8 | 02 | N | 330016249 | GEMCARBO |
| 330008261 | 330005053 | 1.64 | 55 | Palliative (P) | 2017-08-12 | 2017-08-18 | Cyclophosphamide + Topotecan | N | N | 330016249 | CISPLATIN + ETOPOSIDE |
| 330008262 | 330008762 | null | null | Curative (C) | 2017-02-25 | 2017-02-26 | Temozolomide 150mg/m2 | null | N | 330016269 | VINBLASTINE |
| 330008263 | 330005055 | 1.74 | 81.8 | Disease modification (D) | 2014-06-14 | 2014-05-19 | NIVOLUMAB | 02 | null | 330016269 | DA |
| 330008264 | 330005056 | 0 | null | Curative (C) | 2016-04-20 | 2016-04-21 | Azacitidine | N | N | 330016281 | CAV |
| 330008265 | 330005056 | 1.67 | 72.1 | Curative (C) | 2013-10-05 | 2013-10-16 | NIVOLUMAB | 2 | N | 330016281 | CISPLATIN + DOXORUBICIN |
| 330008266 | 330005056 | 1.68 | 18.8 | Disease modification (D) | 2016-01-05 | 2016-04-04 | CAV | 02 | null | 330016281 | VINBLASTINE |
| 330008267 | 330005056 | 0 | 75 | Curative (C) | 2013-08-14 | 2013-08-31 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330016281 | LIPOSOMAL DOXORUBICIN |
| 330008268 | 330005057 | 1.62 | 87.8 | Palliative (P) | 2016-04-20 | 2016-06-11 | GemCarbo Days 1+8 | N | N | 330016313 | GEMCARBO |
| 330008269 | 330005057 | 1.74 | 65.5 | Palliative (P) | 2014-08-09 | 2014-08-17 | Methotrexate intrathecal | N | N | 330016313 | METHOTREXATE INTRATHECAL |
| 330008270 | 330005059 | 1.58 | 67 | Palliative (P) | 2016-05-10 | 2016-05-13 | Docetaxel | 02 | N | 330016332 | DOCETAXEL |
| 330008271 | 330005060 | 1.7 | 61 | Curative (C) | 2016-07-29 | 2016-09-12 | Liposomal Doxorubicin (Caelyx) | N | N | 330016340 | LIPOSOMAL DOXORUBICIN |
| 330008272 | 330008767 | 1.75 | 78.3 | Curative (C) | 2014-07-23 | 2014-07-27 | Cisplatin + Doxorubicin | N | N | 330016382 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008273 | 330008767 | 1.72 | 15.2 | Palliative (P) | 2017-04-02 | 2017-04-09 | Docetaxel 75mg/m2 (21 day) | N | N | 330016382 | DOCETAXEL |
| 330008274 | 330008767 | null | null | Neo-adjuvant (N) | 2017-06-03 | 2017-06-30 | EW EuroEwing 99 : VActI | 2 | null | 330016382 | EURO-EWING |
| 330008275 | 330005064 | 1.24 | 61.8 | Curative (C) | null | 2016-06-26 | FLAG + Idarubicin | 2 | N | 330016407 | FLAG + IDARUBICIN |
| 330008276 | 330005066 | 1.68 | 114 | null | 2015-07-17 | 2015-12-04 | Docetaxel | N | N | 330016418 | DOCETAXEL |
| 330008277 | 330005066 | 1.93 | 88.3 | Disease modification (D) | 2017-10-22 | 2017-11-12 | EW EuroEwing 2012 Arm A VIDE | N | N | 330016418 | EURO-EWING |
| 330008278 | 330005067 | null | null | Curative (C) | 2015-11-02 | 2016-01-19 | NIVOLUMAB | N | N | 330016423 | CAV |
| 330008279 | 330005068 | null | 63.8 | Palliative (P) | 2014-03-03 | 2014-03-12 | Liposomal Doxorubicin (Caelyx) | 02 | null | 330016441 | LIPOSOMAL DOXORUBICIN |
| 330008280 | 330005069 | 1.78 | 74.6 | Curative (C) | 2017-09-16 | 2017-10-06 | Cytarabine High Dose | 02 | N | 330016460 | CYTARABINE HIGH DOSE |
| 330008281 | 330005069 | 1.75 | 15.3 | Curative (C) | 2015-05-01 | 2015-05-03 | Etoposide oral | N | N | 330016460 | ETOPOSIDE |
| 330008282 | 330005069 | 0 | 78 | Curative (C) | 2015-02-13 | 2015-02-13 | Methotrexate intrathecal | N | N | 330016460 | METHOTREXATE INTRATHECAL |
| 330008283 | 330008771 | 0 | 80 | Curative (C) | 2015-08-08 | 2015-09-07 | GemCarbo Days 1+8 | 02 | N | 330016503 | GEMCARBO |
| 330008284 | 330008771 | 1.84 | 43.6 | Neo-adjuvant (N) | 2016-03-20 | 2016-03-20 | EURO-EWING | 02 | N | 330016503 | EURO-EWING |
| 330008285 | 330008771 | 1.7 | null | Disease modification (D) | 2014-12-23 | 2014-12-25 | Cytarabine High Dose | 2 | N | 330016503 | CYTARABINE HIGH DOSE |
| 330008286 | 330005072 | null | 58 | Neo-adjuvant (N) | 2014-09-12 | 2014-09-18 | Cisplatin + Etoposide (5 day) | N | N | 330016514 | CAV |
| 330008287 | 330005073 | 1.59 | 124.5 | Curative (C) | 2018-03-04 | 2018-03-21 | Methotrexate intrathecal | N | N | 330016526 | METHOTREXATE INTRATHECAL |
| 330008288 | 330008773 | 1.83 | 63.2 | Palliative (P) | 2016-08-20 | 2016-08-21 | EW Rel rEECur Irinotecan/Temozolomide | N | N | 330016543 | IRINOTECAN + TEMOZOLOMIDE |
| 330008289 | 330005075 | 1.91 | 82 | null | 2016-03-23 | 2016-03-27 | Azacitidine | 02 | N | 330016549 | NIVOLUMAB |
| 330008290 | 330005075 | 1.69 | 55.8 | Curative (C) | 2016-07-12 | 2016-07-16 | Trabectedin | N | Y | 330016549 | TRABECTEDIN |
| 330008291 | 330005075 | null | 57 | Palliative (P) | 2018-05-22 | 2018-05-22 | GemCarbo Days 1+8 | Y | N | 330016549 | GEMCARBO |
| 330008292 | 330005076 | 1.72 | null | Disease modification (D) | 2014-01-27 | 2014-01-31 | FLAG + Idarubicin | N | N | 330016578 | FLAG + IDARUBICIN |
| 330008293 | 330005077 | 1.5 | 87.8 | Palliative (P) | null | 2017-04-25 | Cytarabine High Dose | N | N | 330016585 | CYTARABINE HIGH DOSE |
| 330008294 | 330005080 | 1.75 | 68.6 | Curative (C) | 2017-12-21 | 2017-12-21 | EW EuroEwing 99 : VIDE | 02 | null | 330016588 | EURO-EWING |
| 330008295 | 330005081 | 1.33 | 82.7 | Curative (C) | 2017-09-08 | 2017-09-08 | NIVOLUMAB | null | null | 330016591 | CISPLATIN + ETOPOSIDE |
| 330008296 | 330005082 | 0 | 87.6 | Palliative (P) | 2016-02-15 | 2016-03-14 | Azacitidine | N | N | 330016591 | DA |